The revenue stands at ₹7,587.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.53 per cent from ₹6,864.50 crore. This corresponds to a year-on-year *(YoY) growth of 16.22 per cent.
Operating Profit stands at ₹2,156.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.57 per cent from ₹1,731.50 crore. This corresponds to a year-on-year *(YoY) growth of 13.17 per cent.
PBDT stands at ₹2,167.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 22.42 per cent from ₹1,770.80 crore. This corresponds to a year-on-year *(YoY) growth of 13.81 per cent.
Profit Before Tax stands at ₹1,659.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.59 per cent from ₹1,411.20 crore. This corresponds to a year-on-year *(YoY) decline of 0.45 per cent.
Net Profit stands at ₹1,341.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 31.10 per cent from ₹1,022.90 crore. This represents a 7.82 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Zydus Lifesci. | -0.81% | 0.21% | 5.77% | 24.63% | 27.80% | 18.79% |
| Divi's Lab. | 0.30% | -0.22% | 3.44% | 12.58% | 6.25% | 0.78% |
| Torrent Pharma. | 0.14% | 1.66% | 8.75% | 17.33% | 24.46% | 43.92% |
| Cipla | -0.20% | -2.21% | 4.14% | 18.78% | -0.61% | -3.09% |
| Lupin | -0.35% | 0.14% | 9.79% | 7.94% | 14.67% | 29.68% |
| Mankind Pharma | -0.66% | -0.61% | 6.06% | 21.42% | 14.09% | -6.48% |
| Dr Reddy's Labs | -1.91% | -9.00% | -2.64% | 0.83% | 4.63% | -0.44% |
Chairman (Non-Executive) : Pankaj R Patel
Managing Director : Sharvil P Patel
Non Executive Director : Mukesh M Patel
Independent Director : Apurva S Diwanji
Whole-time Director : Ganesh N Nayak
Independent Director : Bhadresh K Shah
Company Sec. & Compli. Officer : Dhaval N Soni
Independent Director : Akhil A. Monappa
Independent Director : Upasana Konidela.
Independent Director : Shelina P. Parikh